Tangyue

1、Educational Experience

2001-2004 China Pharmaceutical University, Ph. D in Pharmaceutics
1998-2001 China Pharmaceutical University, Master in Pharmaceutics
1992-1997 China Pharmaceutical University, Bachelor in Pharmacology

2、Working Experience

(1) 2018/08-2019/07, Deputy Director of Gaochun District Science and Technology Bureau of Nanjing City (temporary post)

(2) 2014/08-2015/08, Visiting Scholar, School of Human Ecology, Cornell University, USA

(3) 2008/12-present, Associate Professor, School of Pharmacy, China Pharmaceutical University

(4) 2004/07-2008/11, lecturer, School of Pharmacy, China Pharmaceutical University

1. Jing Chen, Yushun Dou, Yue Tang*, Xinru Zhang. Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells[J]. Nanomedicine 2020, 25:102173.

2. Yue Tang*, Yun Liu, Yuwen Xie, Jing Chen, Yushun Dou. Apoptosis of A549 cells by small interfering RNA targeting survivin delivery using poly-β-amino ester/guanidinylated O-carboxymethyl chitosan nanoparticles[J]. Asian Journal of Pharmaceutical Sciences 2020, 15(1):121-128.

3. Yun Liu, Jing Chen, Yue Tang*, Shuhan Li, Yushun Dou, Jiewen Zheng. Synthesis and characterization of quaternized poly(β-amino ester) for highly efficient delivery of small interfering RNA[J]. Molecular Pharmaceutics, 2018,15(10):4558- 4567.

4. Suhui Ni, Yun Liu, Yue Tang*, Jing Chen, Shuhan Li, Ji Pu, Lidong Han. GABAB receptor ligand-directed trimethyl chitosan/tripolyphosphate nanoparticles and their pMDI formulation for survivin siRNA pulmonary delivery [J]. Carbohydrate Polymers, 2018, 179: 135-144.

5. Jing Chen, Yue Tang*, Yun Liu, Yushun Dou. Nucleic Acid-Based Therapeutics for Pulmonary Diseases[J].AAPS PharmSciTech,2018,19(8):3670-3680.

6. Suhui Ni, Yuwen Xie, Yue Tang*, Yun Liu, Jing Chen, Siyan Zhu. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation[J]. Journal of Drug Targeting, 2017, 25(5):451-462.

7. Heyang Zhang, Yuwen Xie, Yue Tang*, Suhui Ni, Bo Wang, Zhen Chen, Xuejing Liu. Development and characterization of thermo-sensitive films containing asiaticoside based on polyvinyl alcohol and Methylcellulose[J]. Journal of Drug Delivery Science & Technology, 2015, 30:133-145.

8. Liqun Jiang, Yue Tang*, Hongjiu Zhang, Xifeng Lu, Xijing Chen, Jiabi Zhu. Importance of Powder Residence Time for the Aerosol Delivery Performance of a Commercial Dry Powder Inhaler Aerolizer (R) [J]. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2012, 25(5): 265-279.

9. Yue Tang*, Heyang Zhang, Xifeng Lu, Liqun Jiang, Xinyuan Xi, Jianping Liu, and Jiabi Zhu. Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation [J]. Drug Delivery, 2015;22(5):608-18. doi: 10.3109/10717544.2013.863526. Epub 2013 Dec 4.2015.

Yue Tang, Jiabi Zhu. Recombinant human interleukin-2 inhalation powders: Preparation and distribution in the alveolus [J]. International Journal of Pharmaceutics, 2008, 360(1-2): 225-227.

（1）National Science and Technology Major Project. New Dosage Forms and New Controlled-release System Technology Platform. 2009.1-2010.12. Completed.

（2）Study on Preparation Technology and Quality Control of Houttuynia cordata Volatile Oil CD Inclusion Compound Eye Drops. Other provincial and ministerial level projects, 2018.12-2020.11. Completed.

（3）Study on Tea Tree Oil Quantitative Aerosol Film Formulation Band-Aid. 2014.8-2016.8. Completed.

（4）Study on solving the irritation problem of gentamicin diclofenac sodium eye drops. 2017.1-2022.1. Completed.

（5）Development of highly effective anti-inflammatory plant essential oils and related products. 2020.11-2025.11. In progress.

1.Application of interleukin-2 as a drug for the treatment of rhinitis.CN 101125199B Patent of invention 1st 2010.07.21China

2.A dry powder inhalation device.CN 203458653U Model utility 1st 2014.03.05China

3.A multi dose storage type dry powder inhalation device.CN2142323338U Model utility 1st 2021.9.21 China

1. Pharmaceutics of Biotechnology Drugs.2018.

ISBN978-7-117-25024-5/R.People's Medical Publishing House.First Editor in Chief.

2.Modern Biopharmaceutics2011.ISBN9787117140539.

People's Medical Publishing House.Editorial Board.

3.Biopharmaceutics Experiment and Guidance.2007.ISBN978-7-5067-3758-6.China Pharmaceutical Science and Technology Press.Editorial Board.